Premaitha Share Discussion Threads

[hjb1] 28/12/2016 22:36

the bloke is not my cup of tea either, but I would be wary of what I said on these forums!

[blackss] 28/12/2016 21:53

The guys a con who prays on the gullible i'm told.

[hjb1] 28/12/2016 21:34

oh dear oh dear!, do we have some disgruntled ex Quindell shareholders here? He certainly got that one right eh. lmao.

[the monkster] 28/12/2016 13:27

well its dropped from 30 to 7 and a penny is not that far away. its not inconceivable...

[albanyvillas] 28/12/2016 07:02

heading for a penny - see chart
hold tight endure pain
hope it helps

[albanyvillas] 27/12/2016 20:14

heading for a penny

[twix386] 27/12/2016 05:15

Ngen,

Firstly, Merry Xmas to you.

Finally some balanced comment, although it would be difficult to spin the Genoma and Revenue news as anything other than negative - even by you! lol Both were indeed disappointing to read.

You could have mentioned one other area I regard as consistently poor - given expectations followed by anti-climax.
At the AGM in October we stated that a number of sizeable commercial partnerships were expected shortly. More than one, yet we have had nothing sizeable as we enter 2017. I do NOT call this 'shortly'! Rather another example of over optimistic and unmet guidence. 'Shortly' should mean within days to perhaps a few weeks, maybe a bit longer, NOT months later and counting for any ONE of the number, stated as due shortly.
I am though hopeful for news in January 2017.

However, otherwise I agree with your positivity and I am hopeful for a much better 2017 - we need it!
Certainly Yourgene purchase has a string of associated benefits and opportunities, not least of which is increasing our strategic worth to TFS.

[ramas] 27/12/2016 00:25

Let's hope the yourgene directors respect the lock in ? As for the 9p issue price this assumes the yourgene directors see this as value vs NIPT overpaying ... in which case selling for less than 9p is not a problem for them , but is for us current holders. Just a couple of thoughts which I hope are unfounded ...

[ngen yap] 26/12/2016 23:06

Hope everyone had a lovely Xmas, and enjoyed some fine food and wine.Let's get it out the way. I was disappointed with the revenue number for H1. Was expecting at least £2m+. Certainly didn't expect the Genoma financial issues either. So, twix, you see, I do do negative. But that is as far as I will say for now. :-)Because whilst the above were disappointing, there is a lot to be positive and confident on. Amongst them:- we now have 13 active labs (versus only 4 at end March 2016);- through geographic expansion, particularly in middle east and Asia, risk being diversified;- increasing number of direct customers;- advanced negotiations with large european diagnostics company;- great stake by thermo via loan and warrants; and finally- the acquisition of yourgene!Perhaps people have glossed over the last point. Firstly, we bought company with an all share offer, with lock ins on the founders, who are now also major shareholders of premaitha. You don't agree that unless you believe the share is worth more in time. It is 9p issue price, more than today! Second, between yourgene and us, we now have a large chunk of nipt testing via thermo kit. This makes us even more important to thermo, wouldn't be surprised that was a milestone. Consolidation via us for thermo. Thirdly, further risk diversification and access to big market. Finally, research capability. I work out acquisition to be valuing yourgene to be circa 3.5 times sales. On equal valuation, that would forecast sales of circa £5.8m for us for ye March 2017. So, perhaps we see sales closer to £4m for next half. Then slowly reaching £6m and £8m in the next two six months. This tallies with director saying we will be cash flow positive in 2nd half of year ending March 2018. If this is the case, then our £7.7m cash plus loan facilities, should just see us through to cash flow breakeven even with legal case, all things being equal of course.Have dipped further in on weakness. My biggest investment to date and hopefully it will reward handsomely. Good luck to all for 2017, may it be premaitha's year!

[hjb1] 25/12/2016 18:21

ha ha! listen to the head of acquisitions..totally clueless!! not quite at your entry level eh? ha ha!

[thinkbig?] 25/12/2016 16:55

Buying another company with out cash to back yourself up is suicide. They are burning 4 mill every 6 months they have 3 months of cash left. Then they have to drawn down on the loan money again.This is living on borrowed time now. NHS not till 2018. Just can not see them sustaining there business plan. They are busy really living on borrowed money.

[twix386] 23/12/2016 14:18

thanks head gardener and I agree.

Maybe meantime I could make a better living with a subscription service on LSE. LOL

It seems some people here want to spread rumour and deramp.
Clearly the price was going down after Genoma news and revenue not as good as hoped, but our acquisition is good in a number of beneficial ways and news will come in January, so this is a short term buying opp and our future actually looks much better, but we need to see the promise delivered and pass through a quite short period of further volatility/weakness.

topazfrenzy,

there will not be time to reach 5p before we have indications and pre-rise on news. aimho

[topazfrenzy] 23/12/2016 14:00

Why twix? Of course if the news stinks then I won't but I am guessing this will go down to 5p just on bad sentiment.

[head gardener] 23/12/2016 13:59

I have to admit to subscibing to HSR, it still has a buy rating, the outlook for the company has never been better and too cheap at current s/p. Twix, avid reader of your column on LSE. Premaitha has made a very large hole in my finances, butI hold great optimism for 2017. Happy Xmas and may you all be filthy rich jn the coming year!

[twix386] 23/12/2016 13:58

you will NOT be adding then!
aimho

[topazfrenzy] 23/12/2016 13:53

I will add at 5p, sold most the other day and a few more this morning, now sitting on 10000 shares which I will hold for the journey, wherever that leads lol

[twix386] 23/12/2016 13:45

sure BlackSS,

My only point is I don't believe the scare tactics from posters above, that he is offloading, even though he's often not credible. I think Premaitha is indeed a Buy with the European partner news soon and something out of asia/m.e due soon. If I had funds I would buy now. The pity is I did it at higher prices.
I absolutely do not think TW is selling, that's all.

[blackss] 23/12/2016 13:37

I dont honestly think anyone really believes anything TW says. He has had these as a buy all the way down from 30p, lets face it if they dont go bust he is going to get it right in the end.

[twix386] 23/12/2016 13:16

I am not a subscriber to HSR, but it will be available in a few days on Shareprophets for free viewing.

I seriously doubt TW is selling, so let's put that untruth to rest!

[twix386] 23/12/2016 13:11

These scare tactics about TW selling are from derampers and liars!

HSR i.e. TW has a note out TODAY titled...
Premaitha: Interims and acquisition: you dont believe us but the shares are a buy

[gnnmartin] 23/12/2016 12:58

I'm surprised at the reaction to the proposed deal. Assuming Yourgene is as it seems, the deal seems to reduce the risk to Premaitha, and shows that Dr. Chang at least has confidence in Premaitha. Is it just distrust of Eastern Promise?